Loading…
BNC Distribution Inc. was cited for selling and distributing e-liquid products without proper FDA authorization under the Family Smoking Prevention and Tobacco Control Act. The company failed to comply with requirements that "new tobacco products"—including e-liquid products containing nicotine from any source—obtain premarket authorization orders before being legally marketed in the United States. The FDA determined that these e-liquid products fell under its jurisdiction as tobacco products under section 901(b) of the Federal Food, Drug, and Cosmetic Act and required compliance with applicable FDA regulations and the 2022 legislative expansion of tobacco product jurisdiction to include nicotine from non-tobacco sources.